Timken (NYSE: TKR), Sequenom (NASDAQ: SQNM), Tractor Supply Co. (NASDAQ: TSCO), WABCO Holdings Inc. (NYSE: WBC), Metals Holdings (NASDAQ: MUSA) and Advance Auto Parts, Inc. (NYSE: AAP) ratings and price targets.
Auriga reiterated its "Buy" rating on Sequenom (SQNM).
Jefferies Group (NYSE:JEF) reiterated its "Buy" rating on Timken (TKR).
Deutsche Bank (NYSE:DB) reiterated its "Buy" rating on Tractor Supply Co. (TSCO). They have a price target of $90.00 on the company.
William Blair initiated coverage on WABCO Holdings Inc. (WBC). They placed an “Outperform” rating on the company.
Metals Holdings (MUSA) was downgraded by Credit Agricole from an “Outperform” rating to an “Underperform” rating.
Advance Auto Parts, Inc. (AAP) was upgraded by UBS AG (NYSE:UBS) from a “Neutral” rating to a “Buy” rating. They have a price target of $90.00 on the company, up from $74.00.
Showing posts with label Sequenom. Show all posts
Showing posts with label Sequenom. Show all posts
Tuesday, January 31, 2012
Timken (TKR) (SQNM) (TSCO) (WBC) (MUSA) (AAP) Ratings, Price Targets
Monday, August 29, 2011
TreeHouse (THS) (ABCD) (WDR) (AFFX) (SQNM) (BLK) Get New Coverage
TreeHouse Foods Inc. (NYSE: THS), Cambium Learning Group (NASDAQ: ABCD), Waddell & Reed Financial, Inc. (NYSE: WDR), Affymetrix, Inc. (NASDAQ: AFFX), Sequenom (NASDAQ: SQNM) and BlackRock, Inc. (NYSE: BLK) getting new coverage from analysts.
Wells Fargo & Co. (NYSE:WFC) initiated coverage on TreeHouse Foods Inc. (THS). They placed an “Outperform” rating on the company.
BMO Capital Markets initiated coverage on Cambium Learning Group (ABCD). They placed an “Outperform” rating on the company.
Jefferies (NYSE:JEF) initiated coverage on Waddell & Reed Financial, Inc. (WDR). They placed a “Buy” rating and a price target of $34.00 on the company.
Mizuho initiated coverage on Affymetrix, Inc. (AFFX). They placed an “Outperform” rating on the company.
William Blair initiated coverage on Sequenom ( SQNM). They placed an “Outperform” rating on the company.
Jefferies initiated coverage on BlackRock, Inc. (BLK). They placed a “Hold” rating and a price target of $177.00 on the company.
Wells Fargo & Co. (NYSE:WFC) initiated coverage on TreeHouse Foods Inc. (THS). They placed an “Outperform” rating on the company.
BMO Capital Markets initiated coverage on Cambium Learning Group (ABCD). They placed an “Outperform” rating on the company.
Jefferies (NYSE:JEF) initiated coverage on Waddell & Reed Financial, Inc. (WDR). They placed a “Buy” rating and a price target of $34.00 on the company.
Mizuho initiated coverage on Affymetrix, Inc. (AFFX). They placed an “Outperform” rating on the company.
William Blair initiated coverage on Sequenom ( SQNM). They placed an “Outperform” rating on the company.
Jefferies initiated coverage on BlackRock, Inc. (BLK). They placed a “Hold” rating and a price target of $177.00 on the company.
Labels:
Affymetrix,
BlackRock,
Cambium Learning,
Jefferies,
Sequenom,
Treehouse Foods,
Waddell and Reed,
Wells Fargo
Friday, August 26, 2011
BlackRock (BLK) (BRCM) (ECTE) (JNS) (SFSF) (SQNM) (SONO) (THS) (WDR) Get New Coverage
BlackRock (NYSE:BLK), Broadcom (NASDAQ:BRCM), Echo Therapeutics (NASDAQ:ECTE), Janus Capital (NYSE:JNS), SuccessFactors (NASDAQ:SFSF), Sequenom (NASDAQ:SQNM), SonoSite (NASDAQ:SONO), TreeHouse Foods (NYSE:THS) and Waddell & Reed (NYSE:WDR) getting new coverage from analysts.
Jefferies (NYSE:JEF) initiated coverage on BlackRock (BLK). They started them off with a "Hold" rating.
ThinkEquity initiated coverage on Broadcom (BRCM). They started them off with a "Buy" rating.
Stifel Nicolaus initiated coverage on Echo Therapeutics (ECTE). They started them off with a "Buy" rating.
Jefferies initiated coverage on Janus Capital (JNS). They started them off with a "Buy" rating.
Piper Jaffray (NYSE:PJC) initiated coverage on SuccessFactors (SFSF). They started them off with a "Overweight" rating.
William Blair initiated coverage on Sequenom (SQNM). They started them off with a "Outperform" rating.
Stifel Nicolaus initiated coverage on SonoSite (SONO). They started them off with a "Buy" rating.
Wells Fargo (NYSE:WFC) initiated coverage on TreeHouse Foods (THS). They started them off with a "Outperform" rating.
Jefferies initiated coverage on Waddell & Reed (WDR). They started them off with a "Buy" rating.
Jefferies (NYSE:JEF) initiated coverage on BlackRock (BLK). They started them off with a "Hold" rating.
ThinkEquity initiated coverage on Broadcom (BRCM). They started them off with a "Buy" rating.
Stifel Nicolaus initiated coverage on Echo Therapeutics (ECTE). They started them off with a "Buy" rating.
Jefferies initiated coverage on Janus Capital (JNS). They started them off with a "Buy" rating.
Piper Jaffray (NYSE:PJC) initiated coverage on SuccessFactors (SFSF). They started them off with a "Overweight" rating.
William Blair initiated coverage on Sequenom (SQNM). They started them off with a "Outperform" rating.
Stifel Nicolaus initiated coverage on SonoSite (SONO). They started them off with a "Buy" rating.
Wells Fargo (NYSE:WFC) initiated coverage on TreeHouse Foods (THS). They started them off with a "Outperform" rating.
Jefferies initiated coverage on Waddell & Reed (WDR). They started them off with a "Buy" rating.
Labels:
BlackRock,
Broadcom,
Echo,
Janus Capital Group,
Jefferies,
Sequenom,
SonoSite,
SuccessFactors,
Treehouse Foods,
Waddell and Reed,
Wells Fargo
Thursday, May 19, 2011
Ratings on (NTCT) (NTES) (PRFT) (SQNM) (STZ) (SYK) Reiterated
Ratings on shares of NetScout Systems, Inc. (NASDAQ: NTCT), Netease.com Inc (NASDAQ: NTES), Perficient, Inc. (NASDAQ: PRFT), Sequenom (NASDAQ: SQNM), Constellation Brands, Inc. (NYSE: STZ) and Stryker (NYSE: SYK) were reiterated by analysts.
Wedbush reiterated an “outperform” rating on NetScout Systems, Inc. (NTCT).
JPMorgan Chase & Co. (NYSE:JPM) reiterated a “buy” rating on Netease.com Inc (NTES).
BGB Securities reiterated a “buy” rating on Perficient, Inc. (PRFT).
Piper Jaffray (NYSE:PJC) reiterated an “overweight” rating on Sequenom (SQNM).
JPMorgan Chase & Co. reiterated a “neutral” rating on Constellation Brands, Inc. (STZ).
Deutsche Bank (NYSE:DB) reiterated a “hold” rating on Stryker (SYK).
Wedbush reiterated an “outperform” rating on NetScout Systems, Inc. (NTCT).
JPMorgan Chase & Co. (NYSE:JPM) reiterated a “buy” rating on Netease.com Inc (NTES).
BGB Securities reiterated a “buy” rating on Perficient, Inc. (PRFT).
Piper Jaffray (NYSE:PJC) reiterated an “overweight” rating on Sequenom (SQNM).
JPMorgan Chase & Co. reiterated a “neutral” rating on Constellation Brands, Inc. (STZ).
Deutsche Bank (NYSE:DB) reiterated a “hold” rating on Stryker (SYK).
Labels:
Constellation Brands,
JP Morgan,
Netease.com,
NetScout,
Perficient,
Sequenom,
Stryker Corp
Monday, May 9, 2011
Top NASDAQ Gainers (OXGN) (EONC) (ACHN) (SQNM) (ELON) on May 6
The top NASDAQ gainers - as measured by percentages Friday on the Exchange - include OxiGene, Inc. (NASDAQ:OXGN), eOn Communications Corporation (NASDAQ:EONC), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Sequenom, Inc. (NASDAQ:SQNM) and Echelon Corporation (NASDAQ:ELON).
OxiGene, Inc. (OXGN) led the NASDAQ gainers, closing at $3.56, up $1.21, or 51.53 percent.
eOn Communications Corporation (EONC) ended the day at $2.81, up $0.71, or 33.81 percent.
Achillion Pharmaceuticals, Inc. (ACHN) closed at $5.68, gaining $1.01, or 21.63 percent.
Sequenom, Inc. (NASDAQ:SQNM) closed at $7.75, rising $1.07, or 16.02 percent.
Echelon Corporation (NASDAQ:ELON) closed Friday at $10.16, climbing $1.36, or 15.45 percent.
OxiGene, Inc. (OXGN) led the NASDAQ gainers, closing at $3.56, up $1.21, or 51.53 percent.
eOn Communications Corporation (EONC) ended the day at $2.81, up $0.71, or 33.81 percent.
Achillion Pharmaceuticals, Inc. (ACHN) closed at $5.68, gaining $1.01, or 21.63 percent.
Sequenom, Inc. (NASDAQ:SQNM) closed at $7.75, rising $1.07, or 16.02 percent.
Echelon Corporation (NASDAQ:ELON) closed Friday at $10.16, climbing $1.36, or 15.45 percent.
Labels:
Achillion Pharma,
EON Communications,
OxiGene,
Sequenom
Friday, May 6, 2011
Coverage on (INFA) (KERX) (SQNM) (XUE) Initiated Today
Coverage on Informatica Co. (NASDAQ: INFA), Keryx Biopharmaceuticals Inc (NASDAQ: KERX), Sequenom (NASDAQ: SQNM) and Xueda Education (NYSE: XUE) initiated by analysts today.
Longbow Research initiated coverage on Informatica Co. (INFA). They placed a “neutral” rating on the company.
MLV Capital initiated coverage on Keryx Biopharmaceuticals Inc (KERX). They placed a “buy” rating and a $18.00 price target on the company.
Auriga initiated coverage on Sequenom (SQNM). They placed a “buy” rating and a price target of $7.00 on the company.
Piper Jaffray initiated coverage on Xueda Education (XUE). They placed an “overweight” rating on the company.
Longbow Research initiated coverage on Informatica Co. (INFA). They placed a “neutral” rating on the company.
MLV Capital initiated coverage on Keryx Biopharmaceuticals Inc (KERX). They placed a “buy” rating and a $18.00 price target on the company.
Auriga initiated coverage on Sequenom (SQNM). They placed a “buy” rating and a price target of $7.00 on the company.
Piper Jaffray initiated coverage on Xueda Education (XUE). They placed an “overweight” rating on the company.
Labels:
Informatica,
Keryx,
Sequenom,
Xueda Education
Friday, January 14, 2011
Sequenom (NASDAQ:SQNM) Boosted by Validity of 4-plex Sequencing
The release of the study by Dennis Lo on the validity of sequencing is considered a positive by Barclays concerning Sequenom (NASDAQ:SQNM).
Barclays stated, "Dennis Lo's much awaited publication on sequencing for NIPD was published in the British Medical Journal. Top-line results of the paper titled 'Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study' were in line with expectations. We remain Overweight into the read-out from SQNM's own 4-plex sequencing based Locked Assay study."
Barclays reiterates an "Overweight" rating on Sequenom, which closed Thursday at $7.33, down $0.17, or 2.27 percent. Barclays has a price target of $9 on them.
Barclays stated, "Dennis Lo's much awaited publication on sequencing for NIPD was published in the British Medical Journal. Top-line results of the paper titled 'Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study' were in line with expectations. We remain Overweight into the read-out from SQNM's own 4-plex sequencing based Locked Assay study."
Barclays reiterates an "Overweight" rating on Sequenom, which closed Thursday at $7.33, down $0.17, or 2.27 percent. Barclays has a price target of $9 on them.
Subscribe to:
Posts (Atom)